AU5513094A - Condensed five-membered heterocyclic compounds - Google Patents
Condensed five-membered heterocyclic compoundsInfo
- Publication number
- AU5513094A AU5513094A AU55130/94A AU5513094A AU5513094A AU 5513094 A AU5513094 A AU 5513094A AU 55130/94 A AU55130/94 A AU 55130/94A AU 5513094 A AU5513094 A AU 5513094A AU 5513094 A AU5513094 A AU 5513094A
- Authority
- AU
- Australia
- Prior art keywords
- condensed
- membered heterocyclic
- heterocyclic compounds
- compounds
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4304650 | 1993-02-16 | ||
| DE4304650A DE4304650A1 (en) | 1993-02-16 | 1993-02-16 | Condensed 5-membered heterocycles, processes for their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5513094A true AU5513094A (en) | 1994-08-18 |
Family
ID=6480585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU55130/94A Abandoned AU5513094A (en) | 1993-02-16 | 1994-02-15 | Condensed five-membered heterocyclic compounds |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0611660A3 (en) |
| JP (1) | JPH072839A (en) |
| AU (1) | AU5513094A (en) |
| CA (1) | CA2115737A1 (en) |
| DE (1) | DE4304650A1 (en) |
| FI (1) | FI940697A (en) |
| IL (1) | IL108648A0 (en) |
| NO (1) | NO940524D0 (en) |
| NZ (1) | NZ250879A (en) |
| ZA (1) | ZA941021B (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2751647B1 (en) * | 1996-07-25 | 1998-09-11 | Synthelabo | BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS |
| BR9812944A (en) | 1997-10-20 | 2000-08-08 | Hoffmann La Roche | Bicyclic kinase inhibitors |
| PL364625A1 (en) | 2001-02-23 | 2004-12-13 | Merck & Co, Inc. | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| KR20040063144A (en) | 2001-11-09 | 2004-07-12 | 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 | Benzimidazoles useful as protein kinase inhibitors |
| WO2004014905A1 (en) | 2002-08-08 | 2004-02-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted benzimidazole compounds |
| EP1988397B8 (en) | 2002-12-19 | 2012-02-15 | The Scripps Research Institute | Compositions and uses for stabilising transthyretin and inhibiting transthyretin misfolding |
| EP1479676A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Benzimidazole-derivatives as factor xa inhibitors |
| US7741341B2 (en) | 2003-05-19 | 2010-06-22 | Sanofi-Aventis Deutschland Gmbh | Benzimidazole-derivatives as factor Xa inhibitors |
| CN1829709A (en) | 2003-08-01 | 2006-09-06 | 健亚生物科技公司 | Bicyclic imidazol derivatives against flaviviridae |
| WO2005112913A1 (en) | 2004-05-20 | 2005-12-01 | The Scripps Research Institute | Transthyretin stabilization |
| EP2222676A4 (en) * | 2007-12-21 | 2011-10-26 | Endacea Inc | A1 adenosine receptor antagonists |
| JP5869677B2 (en) | 2011-09-16 | 2016-02-24 | ファイザー・インク | Solid form of transthyretin dissociation inhibitor |
| EP2956450B1 (en) | 2013-02-14 | 2018-07-25 | Technische Universität München | Hydroxyindalpine derivatives and their medical use |
| US9233961B2 (en) | 2013-03-15 | 2016-01-12 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| US9359359B2 (en) | 2013-03-15 | 2016-06-07 | Hydra Biosciences, Inc. | Substituted xanthines and methods of use thereof |
| US9186361B2 (en) | 2013-03-15 | 2015-11-17 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| AU2014364565B2 (en) | 2013-12-19 | 2017-06-15 | Novartis Ag | [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis |
| EP3165521B1 (en) | 2014-07-03 | 2019-01-16 | Shanghai Institute Of Pharmaceutical Industry | Method of preparing dabigatran etexilate intermediate and intermediate compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2208367B (en) | 1987-07-09 | 1991-07-03 | Alcatel Business Systems | Franking machine |
| US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| DE4124942A1 (en) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS |
| DE4129603A1 (en) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
| DE4214245A1 (en) * | 1992-04-30 | 1993-11-04 | Thomae Gmbh Dr K | Labelled fibrinogen receptor antagonists |
| DE59303178D1 (en) * | 1992-04-28 | 1996-08-14 | Thomae Gmbh Dr K | Tritiated fibrinogen receptor antagonists, their use and methods for their preparation |
-
1993
- 1993-02-16 DE DE4304650A patent/DE4304650A1/en not_active Withdrawn
-
1994
- 1994-02-14 EP EP9494102222A patent/EP0611660A3/en not_active Withdrawn
- 1994-02-14 JP JP6017568A patent/JPH072839A/en active Pending
- 1994-02-15 CA CA002115737A patent/CA2115737A1/en not_active Abandoned
- 1994-02-15 ZA ZA941021A patent/ZA941021B/en unknown
- 1994-02-15 IL IL10864894A patent/IL108648A0/en unknown
- 1994-02-15 NZ NZ250879A patent/NZ250879A/en unknown
- 1994-02-15 AU AU55130/94A patent/AU5513094A/en not_active Abandoned
- 1994-02-15 FI FI940697A patent/FI940697A/en not_active Application Discontinuation
- 1994-02-15 NO NO940524A patent/NO940524D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL108648A0 (en) | 1994-05-30 |
| CA2115737A1 (en) | 1994-08-17 |
| EP0611660A2 (en) | 1994-08-24 |
| ZA941021B (en) | 1995-08-15 |
| EP0611660A3 (en) | 1994-09-14 |
| FI940697A (en) | 1994-08-17 |
| DE4304650A1 (en) | 1994-08-18 |
| NZ250879A (en) | 1995-09-26 |
| FI940697A0 (en) | 1994-02-15 |
| NO940524D0 (en) | 1994-02-15 |
| NO940524L (en) | 1994-08-17 |
| JPH072839A (en) | 1995-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU657350B2 (en) | Heterocyclic compounds | |
| AU2056992A (en) | Heterocyclic compounds | |
| AU5398494A (en) | Five-membered heterocycles | |
| ZW4194A1 (en) | Heterocyclic compounds | |
| GB9304500D0 (en) | Heterocyclic compounds | |
| AU5513094A (en) | Condensed five-membered heterocyclic compounds | |
| GB9321221D0 (en) | Heterocyclic compounds | |
| AU5100396A (en) | Novel heterocyclic compounds | |
| AU8351791A (en) | Heterocyclic compounds | |
| AU5161593A (en) | Heterocyclic compound | |
| AU4982293A (en) | Novel heterocyclic compound | |
| AU7628591A (en) | Heterocyclic compounds | |
| AU5271096A (en) | Novel heterocyclic compounds | |
| AU8542991A (en) | Heterocyclic compounds | |
| AU2894492A (en) | Heterocyclic compounds | |
| IL111756A0 (en) | Heterocyclic compounds | |
| GB9317761D0 (en) | Heterocyclic compounds | |
| AU5270896A (en) | Novel heterocyclic compounds | |
| GB9319243D0 (en) | Heterocyclic compounds | |
| AU8616691A (en) | Heterocyclic compounds | |
| AU7088991A (en) | Heterocyclic compounds | |
| GB9320574D0 (en) | Heterocyclic compounds | |
| GB9320564D0 (en) | Heterocyclic compounds | |
| ZA943073B (en) | Heterocyclic compounds | |
| HU9500213D0 (en) | Substituted fife-membered heterocyclic compounds |